To demonstrate this feature, we specified EGFR vIII (exons 2–7 deletion), a known oncogenic driver in glioblastoma, in the target output file when analyzing FFPE samples from 35 glioblastoma cases (mean age 54.8 years, male 65.7%). The gene discussed is EGFR; the disease is glioblastoma.